StockData
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR) stock

ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3031% above fair value
$41.37−2.28 (-5.22%)

Close on Nov 20, 2026Market cap $5.84BP/E –Yield –

Arrowhead Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Arrowhead Pharmaceuticals figures

See a number that looks wrong?